Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early post-stroke spasticity reduction with botulinum toxin A added to CARAS rehabilitation
NL-OMON43425Recruiting
- Sponsor
- Adelante Therapeutics
- Start
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in stroke and Muscle spasm (2 arms), sponsored by Adelante Therapeutics. Primary endpoint: Action Research Arm Test. Started Aug 2016; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
strokeMuscle spasm
Beyond the preview
Go deeper on NL-OMON43425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43425.